MedTrace Logo

Topical Bimatoprost in the Treatment of Migraine

NCT03419715 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2019-04-26

No results posted yet for this study

Summary

The study is to assess the effectiveness of topically applied bimatoprost in reducing migraine headache frequency, severity, and duration. It will also assess the effect of topical bimatoprost on quality of life.

Conditions

  • Migraine Disorders
  • Headache Disorders

Interventions

DRUG

Bimatoprost Topical Solution

One drop of bimatoprost topical solution is applied daily to the lunula region of the fingernail bed

DRUG

Control

One drop of saline solution is applied daily to the lunula of the fingernail bed on one hand.

Sponsors & Collaborators

  • Manistee Partners

    lead INDUSTRY

Principal Investigators

  • Robert L Bratzler, PhD · Manistee Partners

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-05
Primary Completion
2019-04-25
Completion
2019-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03419715 on ClinicalTrials.gov